Äèñêóññèîííûé Êëóá

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Àêóøåðñòâî è ãèíåêîëîãèÿ > Àíòèôîñôîëèïèäíûé ñèíäðîì

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 19.10.2007, 20:23
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,756
Ïîáëàãîäàðèëè 33,414 ðàç(à) çà 31,759 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ê ñîæàëåíèþ, íèêîãî íå çíàþ â Óêðàèíå...

Thromb Haemost. 1995 Mar;73(3):362-7.
Use of a low-molecular weight heparin (enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity.
Gris JC, Neveu S, Tailland ML, Courtieu C, Marès P, Schved JF.
Laboratoire d'Hématologie, University Hospital, Nîmes, France.

An impaired fibrinolytic capacity, defined as an insufficient venous occlusion-induced shortening of the plasma euglobulin clot lysis time, is a common feature in women suffering from primary early recurrent unexplained miscarriages. We investigated the therapeutic effect of a low-molecular-weight heparin and of a phenformin-like substance. In a prospective, randomized trial, 30 consecutive patients initially received either enoxaparin, 20 mg per day during one month, or moroxydine chloride, 1200 mg per day during one month. In case of fibrinolytic status normalization, they were treated during 6 months by the beneficial treatment which was planned to be continued during eventual pregnancies. Patients with hypofibrinolysis persistence received the alternative treatment during another month and a new evaluation was performed. No treatment was given when a persistent abnormal response to the venous occlusion test was evidenced. In case of positive response, the treatment was continued during 6 months. The primary study end-points consisted of any of the following: effect of the treatments on the fibrinolytic response; number of patients becoming pregnant during the 6 months following the last venous occlusion test; number of full-term pregnancies. Concerning the effects on the fibrinolytic system, 20 out of 29 women responded to the first or second-line enoxaparin treatment whereas only 1 woman out of 19 responded to moroxydine chloride (p = 0.00002). Concerning the effects on fertility, responders to LMWH were more likely to initiate a new pregnancy than non-responders (16/20 vs 2/10, p = 0.002). In patients conceiving, LMWH responders were more likely to obtain live births than nonresponders (13/16 vs. 0/2, p = 0.02).
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #17  
Ñòàðûé 20.10.2007, 12:52
leksi leksi âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 27.11.2006
Ãîðîä: Êàçàíü
Ñîîáùåíèé: 7
leksi *
Óâàæàåìûé Âàäèì Âàëåðüåâè÷!
Ïðîøó Âàñ ïðîêîìåíòèðîâàòü ðåçóëüòàòû ìîåé ãåìîñòàçèîãðàììû è äàòü ðåêîìåíäàöèè:
êîàëèíîâîå âðåìÿ 76 ñ.(íîðìà-73)
êàîëèíîâîå âðåìÿ â ñìåñè ñ äîíîðñêîé ïëàçìîé-75
ÏÒÂ ñ ðàçâåäåííûì òðîìáîïëàñòèíîì-44 (íîðìà-42)
ÏÒÂ ñ ðàçâåäåííûì òðîìáîïëàñò.â ñìåñè ñäîíîðñê.ïëàçìîé-44
ãàäþêà ðàññåëà-57 (íîðìà-53)
ãàäþêà ðàññåëà â ñìåñè ñ äîíîðñê.ïëàçìîé-57
ÒÂ-13 (êîíòðîëü-15)
ÐÔÌÊ 2,0 ìã\100 ìë (íîðìà 3\100)
ôèáðèíîãåí, àêòèâíîñòü ïðîòåèíîâ C,S, óðîâåíü ïëàçìèíîãåíà, ðåçèñòåíòíîñòü V ôàêòîðà, ÀÒ-III è XII-à çàâèñèìûé ôèáðèíîëèç-íîðìà.
Ñïîíòàííàÿ àãðåãàöèîííàÿ àêòèâíîñòü òðîìáîöèòîâ 0,065 (íîðìà 0-0,05)
Èíäóöèðîâàííàÿ àãðåãàöèîííàÿ àêòèâíîñòü òðîìáîöèòîâ
ìàêñ.àìïëèòóäà 71,5% (íîðìà-50-70)
ìàêñ.ñêîðîñòü-â íîðìå.
Ñåé÷àñ áåðåìåííîñòü 3 íåäåëè. Âïðîøëîì 2 ïðåðâàâøèõñÿ áåðåìåííîñòè íà ñðîêå 6 è 10 íåäåëü. ßóæå îáðàùàëàñü ê Âàì è íàäåþñü íà Âàøó ïîìîùü è ñåé÷àñ. Ñïàñèáî çàðàíåå. Åëåíà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #18  
Ñòàðûé 20.10.2007, 21:46
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,756
Ïîáëàãîäàðèëè 33,414 ðàç(à) çà 31,759 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íèêàêèõ îòêëîíåíèé íåò...
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #19  
Ñòàðûé 22.10.2007, 15:17
leksi leksi âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 27.11.2006
Ãîðîä: Êàçàíü
Ñîîáùåíèé: 7
leksi *
Âàäèì Âàëåðüåâè÷, áîëüøîå ñïàñèáî çà îòâåò.
À óäëèíåíèå ÏÒ ñ äîáàâëåíèåì äîíîðñêîé ïëàçìû è òåñò ãàäþêè Ðàññåëà íå îçíà÷àåò ÂÀ? Ìíå íàçíà÷èëè ôðàêñèïàðèí 0,3 è ïîñëå ïåðâîãî æå óêîëà íà÷àëèñü êîðè÷íåâûå âûäåëåíèÿ, ñåé÷àñ ëåæó, óêîëû ïîêà îòìåíèëè. Åñëè ÷òî-òî ïîñîâåòóåòå äëÿ ñîõðàíåíèÿ ìîåé áåðåìåííîñòè áóäó Âàì î÷åíü áëàãîäàðíà! Íà ÷òî åùå ïî Âàøåìó ñëåäóåò îáðàòèòü âíèìàíèå, êàê ìîæíî åùå ïîäñòðàõîâàòüñÿ? Ñïàñèáð çà Âàøè êîíñóëüòàöèè. Åëåíà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #20  
Ñòàðûé 22.10.2007, 21:00
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,756
Ïîáëàãîäàðèëè 33,414 ðàç(à) çà 31,759 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íîðìà äëÿ òàêèõ òåñòîâ íå ìîæåò áûòü îäíîé öèôðîé, à âñåãäà äèàïàçîí îò è äî, 2 ñåêóíäû - íå óäëèíåíèå, à òî÷íîñòü ìåòîäà, êàê ïðàâèëî ïîä óäëèíåíèåì ïîíèìàþò ïîâûøåíèå íà 25% îò íîðìû è áîëåå...

Ôðàêñè íå íóæåí, åñëè ïðèíèìàåòå 1000 ìêã (1 ìã) ôîëèåâîé êèñëîòû, òî áîëüøå íè÷åãî íå ïîêàçàíî...
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #21  
Ñòàðûé 25.10.2007, 16:34
elegen elegen âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2007
Ãîðîä: ã.Îäåññà
Ñîîáùåíèé: 48
Ñêàçàë(à) ñïàñèáî: 6
elegen ýòîò ó÷àñòíèê èìååò íå î÷åíü õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé Âàäèì Âàëåðüåâè÷, íåò ëè ññûëîê íà ðóññêîì, ê ñâîåìó ñòûäó àíãëèéñêèé òîëüêî ðàçãîâîðíûé. Ïîæàëóéñòà, êàêîé ó ìåíÿ äèàãíîç, êàêîâû ïåðñïåêòèâû?
Ñ óâàæåíèåì, Åëåíà. Ñïàñèáî çà ó÷àñòèå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #22  
Ñòàðûé 25.10.2007, 16:44
elegen elegen âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2007
Ãîðîä: ã.Îäåññà
Ñîîáùåíèé: 48
Ñêàçàë(à) ñïàñèáî: 6
elegen ýòîò ó÷àñòíèê èìååò íå î÷åíü õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Ïðîñòèòå, äîáàâëþ. Ïðè¸ì íèçêîìîëåêóëÿðíîãî ãåïàðèíà âî âðåìÿ áåðåìåííîñòè íå ðåêîìåíäóåòñÿ (èç èíñòðóêöèè). Êàê ñ ýòèì áûòü?
Ñ óâàæåíèåì, Åëåíà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #23  
Ñòàðûé 25.10.2007, 23:08
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,756
Ïîáëàãîäàðèëè 33,414 ðàç(à) çà 31,759 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íå çíàþ äîñëîâíî íà ðóññêîì, íî çà ðóáåæîì åòî íàçûâàåòñÿ ïðèâû÷íîå íåâûíàøèâàíèå, îáóñëîâëåííîå íàðóøåíèåì ãåìîñòàçà (ñíèæ. ôèáðèíîëèç). Øàíñû äîíîñèòü è ðîäèòü ðåáåíêà áåç ëå÷åíèÿ 25-35%, ñ ñîîòâ. ëå÷åíèåì 70-90%.
Îôèöèàëüíî ïðîäàâöû ÍÌ ãåïàðèíà ïèøóò åòî â èíñòðóêöèè, íî äîêòîðà ïðèìåíÿþò åãî ïðè áåðåìåííîñòè óæå ñ êîíöà 90-õ, âìåñòî íåãî ìîæíî îáû÷íûé ãåïàðèí, íî åãî íóæíî êîëîòü íå ìåíåå 2 ðàç â äåíü, ÷òî ïðîáëåìàòè÷íî ïîðîé äëÿ áåðåìåííîé íà ïðîòÿæåíèè 7-8 ìåñ.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #24  
Ñòàðûé 09.11.2007, 15:53
elegen elegen âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2007
Ãîðîä: ã.Îäåññà
Ñîîáùåíèé: 48
Ñêàçàë(à) ñïàñèáî: 6
elegen ýòîò ó÷àñòíèê èìååò íå î÷åíü õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé Âàäèì Âàëåðüåâè÷, áëàãîäàðþ çà ïîëíûé îòâåò. Ìîæåò áûòü âû ïîäñêàæèòå, ÷åì îáóñëîâëåí íàðóøåíèå ãåìîñòàçà (ñíèæ. ôèáðèíîëèç)? Ìîæíî ëè ïîâëèÿòü íà ôèáðèíîëèç äðóãèì îáðàçîì? È ïîñëåäíåå, åñëè áåç ïðè¸ìà ÍÌ ãåïàðèíà íå îáîéòèñü, íà÷èíàòü ïðè¸ì îíîãî íóæíî óæå äî áåðåìåííîñòè?
Îãðîìíîå ñïàñèáî.
Ñ óâàæåíèåì, Åëåíà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #25  
Ñòàðûé 09.11.2007, 20:24
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,756
Ïîáëàãîäàðèëè 33,414 ðàç(à) çà 31,759 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Îïèñûâàþòñÿ â ëèòåðàòóðå 2 ïðè÷èíû òàêèõ íàðóøåíèé: âðîæäåííàÿ ìóòàöèÿ áåëêà ñóïðåññîðà ôèáðèíîëèçà, ïðèâîäÿùàÿ ê åãî ïîâûø. êîíöåíòðàöèè (4G4G mutation of PAI-1) èëè åãî ïîâûøåíèå ïðè íàëè÷èè ñèíäðîìà ïîëèêèñòîçíûõ ÿè÷íèêîâ.  ñëó÷àå äèàãíîñòèêè òàêîãî ñèíäðîìà êðîìå ãåïàðèíà åùå íàçíà÷àþò è ìåòôîðìèí.

Êàê ïðàâèëî ÍÌãåïàðèí íàçíà÷àåòñÿ ñ ïåðâûõ (4-6-îé) íåäåëü áåðåìåííîñòè è äî 34-36.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #26  
Ñòàðûé 13.11.2007, 14:28
elegen elegen âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2007
Ãîðîä: ã.Îäåññà
Ñîîáùåíèé: 48
Ñêàçàë(à) ñïàñèáî: 6
elegen ýòîò ó÷àñòíèê èìååò íå î÷åíü õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé Âàäèì Âàëåðüåâè÷, áëàãîäàðþ Âàñ çà âíèìàíèå, îïûò è çíàíèÿ. Ñëîâàìè íå âûðàçèòü áëàãîäàðíîñòü, êîòîðóþ ÿ õî÷ó âûðàçèòü. Ñïàñèáî.
Êàê òîëüêî âñå íàøè ñòàðàíèÿ óâåí÷àþòñÿ óñïåõîì îáÿçàòåëüíî äàì çíàòü î ñåáå.
Îãðîìíîå ñïàñèáî.
Ñ óâàæåíèåì, Åëåíà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #27  
Ñòàðûé 18.12.2007, 23:38
elegen elegen âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2007
Ãîðîä: ã.Îäåññà
Ñîîáùåíèé: 48
Ñêàçàë(à) ñïàñèáî: 6
elegen ýòîò ó÷àñòíèê èìååò íå î÷åíü õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé Âàäèì Âàëåðüåâè÷, ìíå óäàëîñü íàéòè âðà÷à ãèíåêîëîãà, êîòîðûé ïèñàë íàó÷íûé òðóä ïî ãåìàòîëîãèè. Ïåðâîå íàçíà÷åíèå: ãèðóäîòåðàïèÿ 8-10 ñåàíñîâ. Óæå ðàçæèæàþ êðîâü.
Îãðîìíîå Âàì ñïàñèáî.
Ñ óâàæåíèåì, Åëåíà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #28  
Ñòàðûé 19.12.2007, 01:00
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,756
Ïîáëàãîäàðèëè 33,414 ðàç(à) çà 31,759 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ãèðóäîòåðàïèÿ íå ïîêàçàíà äëÿ ëå÷åíèÿ äàííîãî çàáîëåâàíèÿ, ìíå èñêðåííå æàëü, ÷òî â ã. Îäåññà íåò ñïåöèàëèñòîâ, êîòîðûå ðóêîâîäñòâóþòñÿ ñîâðåìåííûìè ìåä. çíàíèÿìè â ñâîåé ïðàêòèêå.

Êîììåíòàðèè ê ñîîáùåíèþ:
ozinvev îäîáðèë(à):
Golubitskaia îäîáðèë(à): !!!!
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #29  
Ñòàðûé 14.04.2008, 21:45
elegen elegen âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2007
Ãîðîä: ã.Îäåññà
Ñîîáùåíèé: 48
Ñêàçàë(à) ñïàñèáî: 6
elegen ýòîò ó÷àñòíèê èìååò íå î÷åíü õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé Âàäèì Âàëåðüåâè÷, öåëèêîì ïîãðóçèëàñü â ðåøåíèå ñâîåé ïðîáëåìû è íå ïðî÷èòàëà âîâðåìÿ Âàø êîìåíòàðèé ïî ïîâîäó ãèðóäîòåðàïèè, ïðî÷ëà òîëüêî ñåãîäíÿ (÷åðåç 4 ìåñÿöà).
Çà ïðîøåäøèé ïåðèîä ïðîøëà êóðñ ãèðóäîòåðàïèè, ïîñëå ïðèíèìàþ ïî 1 òàá. â äåíü Aspecardum 100. Áåðåìåííîñòü íå íàñòóïàëà.
Åñëè ìîæíî ïðîêîìåíòèðóéòå, ïîæàëóéñòà, Ôèáðèíîëèç - òåñò(11.04.08): ÕIIà êàëëèêðåèí-çàâèñèìûé - 15 (4-10 ìèí.)
Ñïîíòàííûé ýóãëîáóëèíîâûé - 187 (180-240)
Ýóãëîáóëèíîâûé, èíäóöèðîâàííûé ñòðåïòîêèíàçîé - 260 (75-85 ñåê)
ÈÐÏ (èíäåêñ ðåçåðâà ïëàçìèíîãåíà) - 92,3 (íîðìà 90-110%)
Óìà íå ïðèëîæó, ÷òî äåëàòü. ß òàê äîâåðèëàñü âðà÷ó. Ïîæàëóéñòà, ïîìîãèòå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #30  
Ñòàðûé 15.04.2008, 20:47
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,756
Ïîáëàãîäàðèëè 33,414 ðàç(à) çà 31,759 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâû, òîæå íå ìîãó íè÷åãî ïóòíîãî ïîñîâåòîâàòü, êðîìå êàê íàéòè ãðàìîòíîãî ñïåöèàëèñòà
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 16:20.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.